Protesters Target GSK Over HIV Drug Patent

Law360, New York (August 7, 2006, 12:00 AM EDT) -- Protests have erupted in Thailand as its government prepares to grant a patent to British drug maker GlaxoSmithKline for a popular HIV treatment, despite the fact that an appeal over patentability hasn’t yet been ruled on.

Hundreds of Thai demonstrators, many of them living with HIV/AIDS, staged a noisy protest at GSK’s headquarters in Bangkok, arguing that an increase in the cost of the anti-retroviral will threaten lives.

In the world of generic drugs, such arguments are hardly new. But the activists’ complaints have transcended moral...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.